Lung Cancer
Lung Cancer
Advertisement
The Fellow on CallThe Fellow on Call | April 11, 2023
The group makes the distinction between non-small cell lung cancer, used as an umbrella term, and small cell lung cancer.
Listen Now
The Fellow on CallThe Fellow on Call | March 27, 2023
Lung cancer is one of the most common and deadly malignancies found in oncology, making early detection critical.
The Fellow on CallThe Fellow on Call | March 27, 2023
The third episoide in this series answers: What do you do when performing a biopsy on a suspected metastatic lesion?
The Fellow on CallThe Fellow on Call | March 20, 2023
Dr. Jane Yanagawa explains the importance of preoperative workup, the meaning and function of "VATS," and more.
The Fellow on CallThe Fellow on Call | March 20, 2023
Treating a patient with widespread mNSCLC presents a very different challenge than treating one without distant disease.
The Fellow on CallThe Fellow on Call | March 20, 2023
What's the best approach for treating metastatic non-small cell lung cancers that possess certain mutations?
The Fellow on CallThe Fellow on Call | March 20, 2023
Dr. Jack West of City of Hope shares his thoughts on the ADAURA Trial, IMPOWER010, and CHECKMATE816.
The Fellow on CallThe Fellow on Call | March 20, 2023
The group continues their discussion with the esteemed Dr. Jack West from City of Hope.
The Fellow on CallThe Fellow on Call | March 15, 2023
The group stresses the importance of approaching every case in a stepwise fashion.
The Fellow on CallThe Fellow on Call | March 15, 2023
The team is joined by Evan Osmundson, MD, PhD, to speak about the fundamentals of radiation oncology.
The Fellow on CallThe Fellow on Call | March 15, 2023
The trio continue their discussion with radiation oncologist Dr. Evan Osmundson on everything pertaining to radiation.
The Fellow on CallThe Fellow on Call | March 15, 2023
The group discusses the goals of induction therapies, treatment combinations for neoadjuvant lung cancer therapy, and more.
Patrick DalyLung Cancer | March 6, 2023
In the recent GAP BRAIN trial, researchers evaluated gefitinib, a tyrosine kinase inhibitor (TKI), with or without ...
Patrick DalyLung Cancer | February 21, 2023
Researchers performed a retrospective analysis to identify risk factors and subsequently develop a predictive scoring ...
Patrick DalyLung Cancer | February 6, 2023
In the recently completed CheckMate 817 trial, researchers evaluated flat-dose nivolumab plus weight-adjusted ipilimumab ...
Patrick DalyLung Cancer | January 30, 2023
In JAMA Network Open, researchers evaluated SGM-101, a carcinoembryonic antigen-related cell adhesion molecule type 5 ...
Patrick DalyLung Cancer | January 17, 2023
Following observational studies that suggested an association between psoriasis and lung cancer risk, researchers ...
Patrick DalyLung Cancer | January 12, 2023
In a recent study, researchers evaluated the safety and efficacy of first-line rezivertinib (BPI-7711), a ...
Patrick DalyLung Cancer | September 29, 2022
Researchers investigated the effects of adding programmed cell death 1 (PD-1) inhibition to chemotherapy in patients ...
Patrick DalyLung Cancer | September 27, 2022
In a meta-analysis published in the European Journal of Clinical Pharmacology, researchers reported on the safety and ...
Advertisement
Advertisement
Advertisement
Latest News

May 29, 2023